Story of a Stock

A fundamental screener that adds business story, management commentary, and qualitative context to the numbers.

Explore

Coverage Universe

How Scores Work

Connect

X (Twitter)Telegram group (opens in a new tab)Submit Request

Built by Pranav Yadav

Experimental research workflow for Indian equity scuttlebutt. Not investment advice.

Research platformStory of a Stock

Story of a Stock

Desk Filings Ranking Journal

Sign in Sign up

Q-Line Biotech Limited (QLINE) — concall analysis | Story of a Stock

Q-Line Biotech Limited

New

SoaS score

6.3/10

Outlook-led

The businessHealthcarePharmaceuticals

The story

It all rides on Unit 4 converting installed instruments into recurring reagent demand; the latest call stayed measured on that ramp.

When a section on Q-Line Biotech Limited changes, it gets posted in the Telegram group first.

Join on Telegram→ (opens in a new tab)

Q-Line Biotech Limited

New

SoaS score

6.3/10

Outlook-led

The businessHealthcarePharmaceuticals

Develops and makes IVD diagnostic reagents, instruments, consumables; sells to labs/hospitals in India.

The story

It all rides on Unit 4 converting installed instruments into recurring reagent demand; the latest call stayed measured on that ramp.

Revenue growth · 2Y view

Bear

17-22%

Base

27-32%

Bull

>32%

Where it sits